PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.\', \'Institute of Immunity and Transplantation, University College London, London, United Kingdom; Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.\', \'Department of Clinical Immunology and Allergy, St James\'s University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.\', \'Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom. Electronic address: a.g.richter@bham.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0091-6749(20)32406-410.1016/j.jaci.2020.12.620
?:doi
?:hasPublicationType
?:journal
  • The Journal of allergy and clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 33338534
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all